FinTechFunding

Recce Pharmaceuticals: Appoints new CEO

  • Recce Pharmaceuticals (RCE) Board of Directors has unanimously appointed James Graham as the company’s new CEO
  • James has served as Recce’s Executive Director of Marketing and Business Development for the last five years
  • In addition to his new duties as CEO, James will continue to serve as a Director on the Board
  • His appointment takes effect on August 28, and comes with an annual salary of $300,000
  • James will oversee the company as it approaches a number of critical milestones, including a clinical trial and COVID-19 studies
  • Recce Pharmaceuticals closed 0.37 per cent in the red for $1.36 each
Previous article
Restream: Raises $50M in Series A Financing
Next article
Huon Aquaculture Group: Raises $64M to improve financial position
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Kraken Parent Acquires Bitnomial for $550M, Strengthening Crypto Offerings

This acquisition marks a significant expansion into derivatives trading.Highlights: Kraken's parent company announces $550M acquisition of Bitnomial.Bitnomial is...
FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...